[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2

Clinical trial NCT05579184 · UNKNOWN

Trial details

NCT number: NCT05579184
Sponsor: FutureChem
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer, mCRPC

Start date: 2022-10-30
Primary completion: 2024-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.